EUVIMEDEUVIMED entdecken
Crossref

Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY)

Sofía De La Villa iD, Carlos Sánchez-Carrillo, Celia Sánchez-Martínez, Emilia Cercenado, Belén Padilla, Ana Álvarez-Uría iD, David Aguilera-Alonso, Esther Bermejo, Rafael Ramos, Luis Alcalá, Mercedes Marín, Maricela Valerio und 2 weitere

Journal of Antimicrobial Chemotherapy · 02.08.2023 · 78 (8) · 1948-1954

DOI: 10.1093/jac/dkad188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 16.06.2023. Verfasst von Sofía De La Villa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Doctor Esquerdo 46, 28007 Madrid, Spain. Hauptthemen laut MEDLINE: Sepsis, Gammaproteobacteria, Enterobacteriaceae Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the impact of time to results (TTR) on the outcome of patients with carbapenemase-producing Enterobacterales bloodstream infections (CPE-BSI).

Methods

Times-series study conducted from January 2014 to December 2021, selecting patients with first CPE-BSI episodes. Periods of intervention were defined according to implementation of diagnostic bundle tests in the microbiology laboratory: pre-intervention (January 2014–December 2017) and post-intervention (January 2018–December 2021). TTR was defined as time elapsed from positivity time of the blood culture bottles to physicians’ notification of CPE-BSI episodes, and was evaluated in patients who received inappropriate empirical and switched to appropriate targeted treatment (switch group). Analysis of a composite unfavourable outcome (mortality at Day 30 and/or persistent and/or recurrent bacteraemia) was performed for the total episodes and in the switch group.

Results

One hundred and nine episodes were analysed: 66 pre-intervention and 43 post-intervention. Compared with pre-intervention, patients in the post-intervention period were younger (68 versus 63 years, P = 0.04), had INCREMENT score > 7 (31.8% versus 53.5%, P = 0.02) and unfavourable outcome (37.9% versus 20.9%, P = 0.04). Proportion of TTR > 30 h was more frequent pre-intervention than post-intervention (61.7% versus 35.5%, P = 0.02). In multivariate analysis of the 109 episodes, source other than urinary or biliary (OR 2.76, 95% CI 1.11–6.86) was associated with unfavourable outcome, while targeted appropriate treatment trended to being protective (OR 0.17, 95% CI 0.03–1.00). Considering the switch group (n = 78), source other than urinary or biliary (OR 14.9, 95% CI 3.25–69.05) and TTR > 30 h (OR 4.72, 95% CI 1.29–17.22) were associated with unfavourable outcome.

Conclusions

Decreased TTR in the post-intervention period was associated with the outcome in patients with CPE-BSI episodes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisGammaproteobacteriaEnterobacteriaceae InfectionsHumansAnti-Bacterial AgentsRetrospective Studiesbeta-LactamasesBacterial Proteins

Substanzen

carbapenemaseAnti-Bacterial Agentsbeta-LactamasesBacterial Proteins

Autor:innen und Institutionen

  • Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Doctor Esquerdo 46, 28007 Madrid, Spain.
  • Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
  • CIBER Enfermedades Respiratorias, CIBERES (CB06/06/0058), Instituto de Salud Carlos III, Madrid, Spain.
  • Medicine Department, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
  • Department of Pediatric Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • CIBER de Enfermedades Infecciosas-CIBERINFEC (CB21/13/00049), Instituto de Salud Carlos III, Madrid, Spain.

ORCID-Profile: Sofía De La Villa, Ana Álvarez-Uría, Patricia Muñoz

Zitieren

APA

De La Villa, S., Sánchez-Carrillo, C., Sánchez-Martínez, C., Cercenado, E., Padilla, B., Álvarez-Uría, A., Aguilera-Alonso, D., Bermejo, E., Ramos, R., Alcalá, L., Marín, M., Valerio, M., Urbina, L., & Muñoz, P. (2023). Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY). Journal of Antimicrobial Chemotherapy, 78(8), 1948-1954. https://doi.org/10.1093/jac/dkad188

Vancouver

De La Villa S, Sánchez-Carrillo C, Sánchez-Martínez C, Cercenado E, Padilla B, Álvarez-Uría A, et al. Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY). Journal of Antimicrobial Chemotherapy. 2023;78(8):1948-1954. doi:10.1093/jac/dkad188

BibTeX
@article{DeLaVilla2023,
  author = {De La Villa, Sofía and Sánchez-Carrillo, Carlos and Sánchez-Martínez, Celia and Cercenado, Emilia and Padilla, Belén and Álvarez-Uría, Ana and Aguilera-Alonso, David and Bermejo, Esther and Ramos, Rafael and Alcalá, Luis and Marín, Mercedes and Valerio, Maricela and Urbina, Luciana and Muñoz, Patricia},
  title = {Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY)},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  volume = {78},
  number = {8},
  pages = {1948--1954},
  doi = {10.1093/jac/dkad188}
}
Kostenlos starten →